Proarrhythmic effect of adenosine in a patient with atrial flutter.

PubWeight™: 0.93‹?›

🔗 View Article (PMC 1025237)

Published in Br Heart J on July 01, 1993

Authors

A K Slade1, C J Garratt

Author Affiliations

1: Department of Cardiology, Royal Brompton National Heart and Lung Hospital, London.

Articles by these authors

Adenosine and supraventricular tachycardia. N Engl J Med (1991) 1.83

New training guidelines: what are the implications for cardiological research? Heart (1996) 1.52

QT dispersion and mortality after myocardial infarction. Lancet (1995) 1.42

Role of dispersion of atrial refractoriness in the recurrence of clinical atrial fibrillation; a manifestation of atrial electrical remodelling in humans? Eur Heart J (2001) 1.41

Profibrillatory effects of verapamil but not of digoxin in the goat model of atrial fibrillation. J Cardiovasc Electrophysiol (2000) 1.40

A new evidence base for implantable defibrillator therapy. Eur Heart J (1998) 1.37

Adenosine and cardiac arrhythmias. BMJ (1992) 1.15

Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial. Heart (2003) 1.13

Radiofrequency catheter ablation of Mahaim tachycardia by targeting Mahaim potentials at the tricuspid annulus. Br Heart J (1995) 1.10

Management of hypertension in general practice: agreements with and variations from the British Hypertension Society guidelines. J Hum Hypertens (1995) 1.05

Signal averaged P wave compared with standard electrocardiography or echocardiography for prediction of atrial fibrillation after coronary bypass grafting. Heart (1997) 1.03

Reproducibility and automatic measurement of QT dispersion. Eur Heart J (1996) 1.02

The relationship between insulin association with tissues and insulin action. Biochim Biophys Acta (1966) 1.01

Cost of carrying out clinical diagnostic tests. Br Med J (1978) 0.98

Potential impact of antiarrhythmic drugs versus implantable defibrillators on the management of ventricular arrhythmias: the Midlands trial of empirical amiodarone versus electrophysiologically guided intervention and cardioverter implant registry data. Heart (1998) 0.93

Ventricular tachycardia as default diagnosis in broad complex tachycardia. Lancet (1994) 0.91

Reproducibility of the signal averaged P wave: time and frequency domain analysis. Heart (1997) 0.90

RCPE UK Consensus Conference on 'Approaching the comprehensive management of atrial fibrillation: evolution or revolution?'. J R Coll Physicians Edinb (2012) 0.87

A comparison of intravenous propafenone and flecainide in the treatment of tachycardias associated with the Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol (1991) 0.87

Three-lead measurement of QTc dispersion. J Cardiovasc Electrophysiol (1995) 0.84

Effects of intravenous adenosine on verapamil-sensitive "idiopathic" ventricular tachycardia. Am J Cardiol (1994) 0.83

Reversal of atrial electrical remodeling after cardioversion of persistent atrial fibrillation in humans. Circulation (2000) 0.83

Sibutramine pharmacokinetics in young and elderly healthy subjects. Eur J Clin Pharmacol (1999) 0.83

The accurate measurement of insulin molarity. Biochem J (1969) 0.82

Use of lead adjustment formulas for QT dispersion after myocardial infarction. Br Heart J (1995) 0.82

RCPE UK Consensus Conference on 'approaching the comprehensive management of atrial fibrillation: evolution or revolution?'. J R Coll Physicians Edinb (2012) 0.81

Who needs ventricular stimulation studies? Br Heart J (1994) 0.81

Improved recovery of high frequency P wave energy by selective P wave averaging. Pacing Clin Electrophysiol (1996) 0.81

The effect of mild exercise on glucose uptake in human forearm tissues in the fasting state and after oral glucose administration. Metabolism (1968) 0.81

The association of [131-I]iodo-insulin with rat diaphragm muscle and its effect on glucose uptake. Biochim Biophys Acta (1966) 0.80

Ligand affinities in mutant metmyoglobins. Biochim Biophys Acta (1993) 0.80

The role of atrial electrical remodeling in the progression of focal atrial ectopy to persistent atrial fibrillation. J Cardiovasc Electrophysiol (1999) 0.79

Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia. Lancet (1990) 0.79

An analysis of a structural difference between beef and pork insulin detected by differences in the exchange rates of amide hydrogens as measured by infrared spectroscopy. Eur J Biochem (1971) 0.78

The effect of iodination of particular tyrosine residues on the hormonal activity of insulin. Biochem J (1972) 0.78

Dynamics of QT dispersion during myocardial infarction and ischaemia. Int J Cardiol (1996) 0.78

Preferential depression of conduction around a pivot point in rabbit ventricular myocardium by potassium and flecainide. J Cardiovasc Electrophysiol (2000) 0.78

Direct evidence for an effect of insulin on intracellular metabolism. Int J Biochem (1979) 0.77

The optimal pacing rate: an unpredictable parameter. Pacing Clin Electrophysiol (1997) 0.77

A simple method for determining total glucose utilisation by isolated adipocytes using (5-3H)-glucose. Anal Biochem (1974) 0.77

The effects of adenosine on sinus node reentrant tachycardia. Clin Cardiol (1989) 0.77

Fifty years of tachycardia. Br Heart J (1995) 0.75

Diagnosis of wide complex tachycardia. Pacing Clin Electrophysiol (1996) 0.75

The effectiveness of serial cardioversion therapy for recurrence of atrial fibrillation. Eur Heart J (2002) 0.75

Fast or slow pathway ablation (or neither) for AV nodal tachycardia? Heart (1997) 0.75

Effect of low dose sotalol on the signal averaged P wave in patients with paroxysmal atrial fibrillation. Br Heart J (1995) 0.75

Reperfusion arrhythmias. Cardiovasc Res (1993) 0.75

An effect of fluorescent probes and of insulin on the structure of adipocyte membranes [proceedings]. Biochem Soc Trans (1978) 0.75

The composition and fluidity of adipocyte membranes prepared from young and adult rats. Biochim Biophys Acta (1980) 0.75

The energy balance of triacylglycerol metabolism in isolated rat adipocytes and the effect of insulin. Biochim Biophys Acta (1977) 0.75

Adipose tissue, obesity and insulin. Prog Med Chem (1980) 0.75

The interaction of B29-fluoresceinthiocarbamyl-insulin with adipocyte membranes. FEBS Lett (1980) 0.75

The substrate for atrioventricular "nodal" reentrant tachycardia: is there a "third pathway"? J Cardiovasc Electrophysiol (1993) 0.75

Images in cardiovascular medicine. Sudden cardiac death in arrhythmogenic right ventricular dysplasia. Circulation (2000) 0.75

Advances in catheter ablation. Br J Hosp Med (1996) 0.75

Atrial electrical remodelling and atrial fibrillation. QJM (2000) 0.75

The therapeutic and diagnostic cardiac electrophysiological uses of adenosine. Cardiovasc Drugs Ther (1993) 0.75

Prevalence and significance of focal sources of atrial arrhythmia in patients undergoing cardioversion of persistent atrial fibrillation. J Cardiovasc Electrophysiol (2000) 0.75

Influence of antipsychotic profile on cost of treatment of schizophrenia: A decision analysis approach. Int J Psychiatry Clin Pract (1998) 0.75

Counter-transport of 3-O-methylglucose in rat adipocytes [proceedings]. Biochem Soc Trans (1979) 0.75

The signal averaged P wave in atrioventricular block--evidence for abnormal atrial conduction? Int J Cardiol (1998) 0.75

Flecainide widens the excitable gap at pivot points of premature turning wavefronts in rabbit ventricular myocardium. J Cardiovasc Electrophysiol (2001) 0.75

A simple method for measuring the tricarboxylic acid cycle and pentose phosphate pathway in adipose tissue. Anal Biochem (1978) 0.75

A procedure for the redefinition of equivocal results in thyroid function tests. Ann Clin Biochem (1980) 0.75

The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death. Europace (2004) 0.75

Effect of exercise on peripheral uptake of I-iodo insulin and glucose in nondiabetics. Metabolism (1972) 0.75

Characterization of the uptake of 1,6-diphenylhexa-1,3,5-triene by adipocyte membranes [proceedings]. Biochem Soc Trans (1979) 0.75